CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
49.44
+2.33 (4.95%)
At close: Oct 22, 2026, 4:00 PM EDT
49.44
0.00 (0.00%)
Pre-market: Oct 23, 2026, 4:00 AM EDT

CONMED Revenue

CONMED had revenue of $343.49M in the quarter ending June 30, 2026, with 0.33% growth. This brings the company's total for the last twelve months to $1.37B, up 3.42% year-over-year. In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth. That makes CONMED the 6,301st largest company in the world by revenue and 1,565th in the United States.

Revenue (ttm)
$1.37B
Revenue Growth
+3.42%
P/S Ratio
1.08
Revenue / Employee
$351,707
Employees
3,900
Market Cap
1.48B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • General Surgery 800.13M 58.2%
  • Orthopedic Surgery 574.60M 41.8%

By Geography

Chart
  • United States 774.59M 56.3%
  • Europe, Middle East & Africa 264.65M 19.3%
  • Asia Pacific 208.72M 15.2%
  • Americas (ex-United States) 126.76M 9.2%
Fiscal year ended Dec 31, 2025 See the full CONMED breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.37B67.71M5.18%
Dec 31, 20241.31B62.27M5.00%
Dec 31, 20231.24B199.27M19.06%
Dec 31, 20221.05B34.84M3.45%
Dec 31, 20211.01B148.18M17.18%
Dec 31, 2020862.46M-92.64M-9.70%
Dec 31, 2019955.10M95.46M11.11%
Dec 31, 2018859.63M63.24M7.94%
Dec 31, 2017796.39M32.87M4.31%
Dec 31, 2016763.52M44.35M6.17%
Dec 31, 2015719.17M-20.89M-2.82%
Dec 31, 2014740.06M-22.65M-2.97%
Dec 31, 2013762.70M-4.44M-0.58%
Dec 31, 2012767.14M42.06M5.80%
Dec 31, 2011725.08M11.35M1.59%
Dec 31, 2010713.72M18.98M2.73%
Dec 31, 2009694.74M-47.44M-6.39%
Dec 31, 2008742.18M47.90M6.90%
Dec 31, 2007694.29M47.48M7.34%
Dec 31, 2006646.81M29.51M4.78%
Dec 31, 2005617.31M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Enovis2.30B
Tandem Diabetes Care1.04B
Alphatec Holdings815.05M
NovoCure699.19M
Bioventus581.85M
Artivion471.47M
PROCEPT BioRobotics337.34M
Establishment Labs Holdings245.82M
Revenue Rankings